On investigating the role of interleukin-28B (IL28B) polymorphism in pediatric patients with CHC, one study suggested that IL28B genotype was not a strong predictor of SVR [9], while other studies have shown usefulness of IL28B genotype as a predictor of treatment response [10–12]. The gene discussed is IFNL3; the disease is cryohydrocytosis.